Condition
Crohn's Disease Relapse
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Recruiting2
Withdrawn1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06553053Not ApplicableRecruitingPrimary
Acupuncture Reduces Relapse in Patients With Crohn's Disease: a Superiority Trial
NCT04100005Withdrawn
A Pilot Study to Explore the Role of Gut Flora in Crohn's Disease
NCT05599347Phase 2RecruitingPrimary
Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease
Showing all 3 trials